Apr
10
Wed
Medicine Grand Rounds Blume Memorial Lecture: Twenty-five years of Progress in the Clinical Art of Hematopoietic Cell Transplantation @ LKSC Berg Hall
Apr 10 @ 8:00 am – 9:00 am
Medicine Grand Rounds Blume Memorial Lecture: Twenty-five years of Progress in the Clinical Art of Hematopoietic Cell Transplantation @ LKSC Berg Hall | Palo Alto | California | United States

Presenter: Fred Appelbaum, MD

Professor of Medical Oncology, University of Washington

Executive Vice President and Deputy Director, External Affairs, Fred Hutchinson Cancer Research Center

Dr. Appelbaum is the executive director of SCCA. His work centers on the biology and treatment of acute myeloid leukemia.

Decades of working with cancer patients teaches you to savor everyday pleasures like the teasing notes of coriander and cumin in a simmering pot of curry or getting to hug your child, and it fortifies his resolve to keep moving cancer care forward. He’s determined to improve screening, enhance treatment and stop cancer from returning.

As a medical student in the early 1970s, Dr. Appelbaum happened upon Dr. E. Donnall Thomas’ initial description of bone-marrow transplantation in a medical journal. The pioneering technique eventually earned Thomas the Nobel Prize and transformed leukemia and related cancers, once thought incurable, into highly treatable diseases with survival rates as high as 90 percent.

Bone-marrow transplants became the cornerstone of the newly formed Hutchinson Center, and it wasn’t long before Dr. Appelbaum was recruited to join Thomas’ team of medical mavericks in Seattle making historic inroads against blood cancers.

Now, he holds the job that Thomas once held, and he has spent decades building on Thomas’ groundbreaking innovations. Dr. Appelbaum has been an innovator in his own right, refining transplant procedures, conducting clinical trials and caring for patients.

Part of that job is extending the Hutch’s patient research beyond transplants. We’ve expanded our role in the more common solid tumors and have created nontransplant approaches to blood cancers. We’ve made substantial gains in treating prostate, colon, pancreatic, lung, breast and ovarian cancers, but we have a long way to go.

Oct
29
Thu
Cancer & COVID-19 Community Town Hall @ Online only
Oct 29 @ 3:30 pm – 5:00 pm
Cancer & COVID-19 Community Town Hall @ Online only
Thursday, October 29, 2020 3:30 PM – 5:00 PM, Zoom Link provided upon registration

Register here.

Join Stanford Cancer Institute | Community Outreach & Engagement for a town hall designed for the local and regional community to provide education about the impact of COVID-19 and cancer.
Topics will include:

  • Cancer Screening and Prevention
  • Cancer Patients and Survivors
  • Cancer Patient Finances

Questions can be submitted in advance here or live during the Town Hall

Our featured speakers are:

Co-Sponsored by:
Stanford Cancer Institute Community Outreach and Engagement and
Stanford Medicine Office of Community Engagement